- Title
- Efficacy and Safety of Azacytidine in Combination With Fludarabine and High-Dose Cytarabine With G-CSF (FLAG) in Relapsed/Refractory Acute Myeloid Leukemia: A Nonrandomized, Open-Label, Phase II Study
- Creators - without role
- Ibraheem H. Motabi - King Fahd Medical CityShaima M. Al Aoun - King Fahd Medical CityMaged Al-Ammari - King Fahd Medical CityBelal M. Albtoosh - King Fahd Medical CityShahid Iqbal - Manchester Royal InfirmarySyed Y. Altaf - King Fahd Medical CityImran K. Tailor - King Fahd Medical CityMohammed S. Alnoamani - King Fahd Medical CityMubarak S. AlGhamdi - College Station Medical CenterSyed Z. A. Zaidi - College Station Medical CenterNawal F. AlShehry - King Fahd Medical CityMohammed A. Marei - King Fahd Medical CityMansour Alfayez - King Fahd Medical City
- Publication Details
- Clinical lymphoma, myeloma and leukemia, Vol.21(10), pp.720-723
- Publisher
- Cig Media Group, Lp
- Number of pages
- 4
- Grant note
- 015-016 / King Fahad Medical City Research Center
- Identifiers
- 9913264808331
- Academic Unit
- King Faisal University; Alfaisal University
- Language
- English
- Resource Type
- Journal article
Journal article
Efficacy and Safety of Azacytidine in Combination With Fludarabine and High-Dose Cytarabine With G-CSF (FLAG) in Relapsed/Refractory Acute Myeloid Leukemia: A Nonrandomized, Open-Label, Phase II Study
Clinical lymphoma, myeloma and leukemia, Vol.21(10), pp.720-723
01/10/2021
PMID: 34417161
Metrics
1 Record Views